Transformed cell harboring DNA or RNA encoding sugar chain synthesizing agent having β1,3-N-acetylglucosaminyltransferase activity
View Patent ↗The present invention provides a novel polypeptide having a β1,3-N-acetylglucosaminyltransferase activity, an agent for synthesizing a sugar chain comprising the polypeptide, a process for producing a sugar chain or a complex carbohydrate using the agent for synthesizing a sugar chain, DNA encoding the polypeptide, a process for producing the polypeptide, an antibody against the polypeptide, and a diagnosis method and a medicament for treatment for inflammation, cancer or tumor metastasis using the DNA or the antibody. The present invention is useful for synthesis of a useful sugar chain and diagnosis and treatment for inflammatory diseases, cancer or tumor metastasis.
1. A method for producing a cell having increased activity of a beta 1,3-N-acetylglucosaminyltransferase, which comprises the steps of:
introducing DNA or RNA into a cell to express a polypeptide encoded by the DNA or RNA, wherein said DNA or RNA is selected from the group consisting of the following (a) to (g):
(a) a DNA encoding a polypeptide comprising the amino acid sequence of SEQ ID NO:1 and having a beta 1,3-N-acetylglucosaminyltransferase activity,
(b) a DNA encoding a polypeptide comprising an amino acid sequence of positions 39-378 in the amino acid sequence of SEQ ID NO:1 and having a beta 1,3-N-acetylglucosaminyltransferase activity,
(c) a DNA encoding a polypeptide comprising an amino acid sequence having 95% or more homology with the amino acid sequence in the polypeptide according to (a) or (b), and having a beta 1,3-N-acetylglucosaminyltransferase activity,
(d) a DNA comprising the nucleotide sequence of SEQ ID NO:2 and encoding a polypeptide having a beta 1,3-N-acetylglucosaminyltransferase activity,
(e) a DNA comprising the nucleotide sequence of positions 135 to 1268 of SEQ ID NO:2 and encoding a polypeptide having a beta 1,3-N-acetylglucosaminyltransferase activity,
(f) a DNA comprising the nucleotide sequence of positions 249 to 1268 of SEQ ID NO:2 and encoding a polypeptide having a beta 1,3-N-acetylglucosaminyltransferase activity, and
(g) an RNA comprising a sequence corresponding to the DNA selected from any one of (a) to (g); and
culturing the cells in order to express said polypeptide.
2. A method for producing a cell having increased amount of a poly-N-acetyllactosamine sugar chain, a lacto-series glycolipid (a glycolipid having Galβ1-3GlcNAcβ1-3Galβ1-4Glc-ceramide as a backbone) or a neolacto-series glycolipid (a glycolipid having Galβ1-4GlcNAcβ1-3Galβ1-4-ceramide as a backbone), which comprises the steps of:
introducing DNA or RNA into a cell to express a polypeptide encoded by the DNA or RNA, wherein said DNA or RNA is selected from the group consisting of the following (a) to (g):
(a) a DNA encoding a polypeptide comprising the amino acid sequence of SEQ ID NO:1 and having a beta 1,3-N-acetylglucosaminyltransferase activity,
(b) a DNA encoding a polypeptide comprising an amino acid sequence of positions 39-378 in the amino acid sequence of SEQ ID NO:1 and having a beta 1,3-N-acetylglucosaminyltransferase activity,
(c) a DNA encoding a polypeptide comprising an amino acid sequence having 95% or more homology with the amino acid sequence in the polypeptide according to (a) or (b), and having a beta 1,3-N-acetylglucosaminyltransferase activity,
(d) a DNA comprising the nucleotide sequence of SEQ ID NO:2 and encoding a polypeptide having a beta 1,3-N-acetylglucosaminyltransferase activity,
(e) a DNA comprising the nucleotide sequence of positions 135 to 1268 of SEQ ID NO:2 and encoding a polypeptide having a beta 1,3-N-acetylglucosaminyltransferase activity,
(f) a DNA comprising the nucleotide sequence of positions 249 to 1268 of SEQ ID NO:2 and encoding a polypeptide having a beta 1,3-N-acetylglucosaminyltransferase activity, and
(g) an RNA comprising a sequence corresponding to the DNA selected from any one of (a) to (g); and
culturing the cells in order to express said polypeptide.
3. The method according to any one of claims 1 or 2 , wherein the cell is derived from human, non-human animal, plant, insect or microorganism.
4. The method according to any one of claims 1 or 2 , wherein the cell is a blood cell, a bone marrow cell, a nerve cell, a stem cell, a cancer cell, a Namalwa cell or a derivative of Namalwa cell.
5. The method according to claim 3 , wherein the non-human animal is a mouse.